{"content":"<li class=\"n-box-item date-title\" data-end=\"1392094799\" data-start=\"1392008400\" data-txt=\"Saturday, December 21, 2019\">Monday, February 10, 2014</li><li class=\"n-box-item sa-box-item\" data-id=\"1560001\" data-ts=\"1392075015\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXLL\" target=\"_blank\">AXLL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1560001-axiall-plus-7_6-percent-ah-on-deal-for-proposed-ethane-cracker-in-louisiana\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Axiall +7.6% AH on deal for proposed ethane cracker in Louisiana</a></h4><ul>     <li>Axiall (NYSE:<a href=\"https://seekingalpha.com/symbol/AXLL\" title=\"Axiall Corporation\">AXLL</a>) <font color=\"green\">+7.6%</font> AH as it joins with Korea's Lotte Chemical to announce an agreement to pursue a <a href=\"http://finance.yahoo.com/news/axiall-lotte-chemical-sign-preliminary-220000497.html\" target=\"_blank\">50/50 joint venture</a>  arrangement for the design, construction and operation of a proposed 1M metric ton/year ethane cracker to be located in Louisiana.</li>\n<li>The companies expect to jointly award a  front-end engineering design contract for the cracker in Q1  2014.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1560001\" data-linked=\"Axiall +7.6% AH on deal for proposed ethane cracker in Louisiana\" data-tweet=\"$AXLL - Axiall +7.6% AH on deal for proposed ethane cracker in Louisiana https://seekingalpha.com/news/1560001-axiall-plus-7_6-percent-ah-on-deal-for-proposed-ethane-cracker-in-louisiana?source=tweet\" data-url=\"https://seekingalpha.com/news/1560001-axiall-plus-7_6-percent-ah-on-deal-for-proposed-ethane-cracker-in-louisiana\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1559881\" data-ts=\"1392072102\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1559881-after-hour-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hour Gainers / Losers</a></h4><ul><li><b>Top gainers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/MODN' title='Model N'>MODN</a> <font color='green'>+23.8%</font>. <a href='https://seekingalpha.com/symbol/MERU' title='Meru Networks, Inc.'>MERU</a> <font color='green'>+15.0%</font>. <a href='https://seekingalpha.com/symbol/NLSN' title='Nielsen Holdings N.V.'>NLSN</a> <font color='green'>+6.1%</font>. <a href='https://seekingalpha.com/symbol/PED' title='PEDEVCO Corp.'>PED</a> <font color='green'>+3.6%</font>. <a href='https://seekingalpha.com/symbol/INVN' title='InvenSense'>INVN</a> <font color='green'>+3.3%</font>.</li><li><b>Top losers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/BLOX' title='Infoblox Inc.'>BLOX</a> <font color='red'>-20.8%</font>. <a href='https://seekingalpha.com/symbol/RAX' title='Rackspace Hosting, Inc.'>RAX</a> <font color='red'>-12.7%</font>. <a href='https://seekingalpha.com/symbol/BNNY' title='Annie&#39;s, Inc.'>BNNY</a> <font color='red'>-8.6%</font>. <a href='https://seekingalpha.com/symbol/VLY' title='Valley National Bancorp'>VLY</a> <font color='red'>-8.4%</font>. <a href='https://seekingalpha.com/symbol/WMGI' title='Wright Medical Group, Inc.'>WMGI</a> <font color='red'>-7.9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"1559881\" data-linked=\"After Hour Gainers / Losers\" data-tweet=\"$MODN $MERU $NLSN - After Hour Gainers / Losers https://seekingalpha.com/news/1559881-after-hour-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1559881-after-hour-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1559831\" data-ts=\"1392071625\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACAS\" target=\"_blank\">ACAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1559831-american-capital-results-take-hit-from-mreit-struggles\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Capital results take hit from mREIT struggles</a></h4><ul>\n<li>Net asset value per share of $18.97 is off 2.9% from $19.54 on Sept. 30, and up 6% from a year ago. Stock closed at $15.94 today.</li>\n<li>8.9M shares repurchased during Q at average price of $14.88 each, adding $0.13 to NAV per share. For full year, 40.4M shares repurchased for at average price of $13.90 each, adding $0.66 to NAV per share.</li>\n<li>Fall in NAV in Q4 largely the result of the struggles of American Capital Asset Management (AGNC and MTGE) - <strong>$185M charge</strong> for unrealized depreciation due to reduction in projected management fees. There's also a $152M depreciation charge in American Capital's private finance portfolio driven by declining specific company performance, offset by $115M in unrealized appreciation in European Capital investment.</li>\n<li>\n<a href=\"http://www.americancapital.com/\" target=\"_blank\">CC</a> tomorrow at 11 ET</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/ACAS\" title=\"American Capital\">ACAS</a> <font color=\"red\">-5.9%</font> AH to $15.00.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1559831\" data-linked=\"American Capital results take hit from mREIT struggles\" data-tweet=\"$ACAS - American Capital results take hit from mREIT struggles https://seekingalpha.com/news/1559831-american-capital-results-take-hit-from-mreit-struggles?source=tweet\" data-url=\"https://seekingalpha.com/news/1559831-american-capital-results-take-hit-from-mreit-struggles\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1559741\" data-ts=\"1392070739\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INVN\" target=\"_blank\">INVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1559741-invensense-stmicroelectronics-settle-patent-dispute-invn-plus-3_3-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InvenSense, STMicroelectronics settle patent dispute; INVN +3.3% AH</a></h4><ul>\n<li>MEMS motion sensor archrivals InvenSense (NYSE:<a href=\"https://seekingalpha.com/symbol/INVN\" title=\"InvenSense\">INVN</a>) and STMicroelectronics (NYSE:<a href=\"https://seekingalpha.com/symbol/STM\" title=\"STMicroelectronics NV\">STM</a>) have settled their <a href=\"http://www.bloomberg.com/news/2013-05-14/invensense-ups-legal-debate-with-stmicro-on-mems-patents.html\" target=\"_blank\">long-running</a> patent dispute and entered into a cross-licensing agreement.</li>\n<li>Deal terms are confidential; neither company \"has made any admission of liability.\" InvenSense and STMicro had been waging legal battles at multiple U.S. courts, as well as with the USPTO and ITC.</li>\n<li>InvenSense investors have responded by bidding shares back above $20. They <font color=\"green\">rose 5.8%</font> in regular trading.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1559741\" data-linked=\"InvenSense, STMicroelectronics settle patent dispute; INVN +3.3% AH\" data-tweet=\"$INVN $INVN $STM - InvenSense, STMicroelectronics settle patent dispute; INVN +3.3% AH https://seekingalpha.com/news/1559741-invensense-stmicroelectronics-settle-patent-dispute-invn-plus-3_3-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1559741-invensense-stmicroelectronics-settle-patent-dispute-invn-plus-3_3-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1559681\" data-ts=\"1392070173\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PXD\" target=\"_blank\">PXD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1559681-pioneer-natural-minus-2_1-percent-ah-as-q4-swings-to-loss-on-writedowns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pioneer Natural -2.1% AH as Q4 swings to loss on writedowns</a></h4><ul>\n<li>Pioneer Natural Resources (NYSE:<a href=\"https://seekingalpha.com/symbol/PXD\" title=\"Pioneer Natural Resources Company\">PXD</a>) <font color=\"red\">-2.1%</font> AH after reporting an <a href=\"https://seekingalpha.com/news/1559261-pioneer-natural-resources-company-beats-by-0_01-beats-on-revenue\" target=\"_blank\">unadjusted Q4 loss of $1.37B</a>, or $9.82/share, including of $1.5B loss related to discontinued operations and assets held for sale, vs. a year-ago profit of $28M, or $0.22/share, a year earlier.</li>\n<li>Forecasts 14%-19% production growth from continuing operations in 2014 based on planned drilling capital expenditures  of $3B; growth will be second-half weighted  as PXD ramps up its drilling program in the northern  Spraberry/Wolfcamp from five rigs at year-end 2013 to 16 rigs by the end  of Q1.</li>\n<li>Added proved reserves of 141M boe during 2013, equating replacement of 211% of PXD's FY 2013 production of 67M boe.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1559681\" data-linked=\"Pioneer Natural -2.1% AH as Q4 swings to loss on writedowns\" data-tweet=\"$PXD - Pioneer Natural -2.1% AH as Q4 swings to loss on writedowns https://seekingalpha.com/news/1559681-pioneer-natural-minus-2_1-percent-ah-as-q4-swings-to-loss-on-writedowns?source=tweet\" data-url=\"https://seekingalpha.com/news/1559681-pioneer-natural-minus-2_1-percent-ah-as-q4-swings-to-loss-on-writedowns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1559661\" data-ts=\"1392070138\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLOX\" target=\"_blank\">BLOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1559661-infoblox-issues-fq2-fy14-warning-shares-minus-29_1-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infoblox issues FQ2/FY14 warning, shares -29.1% AH</a></h4><ul>\n<li>Infoblox (NYSE:<a href=\"https://seekingalpha.com/symbol/BLOX\" title=\"Infoblox Inc.\">BLOX</a>) expects to report FQ2 (Jan. quarter) revenue of $60M-$61M, below prior guidance of $65M-$66M and a $65.7M consensus. EPS is expected to be in a range of $0.10-$0.12 vs. a prior range of $0.09-$0.11 and a $0.10 consensus.</li>\n<li>In addition, the maker of networking/security management appliances now forecasts FY14 (ends July '14) revenue of $250M-$254M (below prior guidance of $$270M-$276M and a $274.5M consensus), and FY14 EPS of $0.30-$0.34 (below prior guidance of $0.44-$0.54 and a $0.52 consensus).</li>\n<li>Infoblox blames weak January sales, fewer-than-expected $1M+ deals, and soft federal demand.</li>\n<li>Shares <a href=\"https://seekingalpha.com/news/1434721-infoblox-plunges-22_2-percent-ah-on-light-guidance-and-heavy-expectations\" target=\"_blank\">crashed in November</a> in response to investor disappointment with Infoblox's original FQ2 forecast. They're now at the lowest levels seen since last spring.</li>\n<li>FQ2 results are due on Feb. 26.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1559661\" data-linked=\"Infoblox issues FQ2/FY14 warning, shares -29.1% AH\" data-tweet=\"$BLOX - Infoblox issues FQ2/FY14 warning, shares -29.1% AH https://seekingalpha.com/news/1559661-infoblox-issues-fq2-fy14-warning-shares-minus-29_1-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1559661-infoblox-issues-fq2-fy14-warning-shares-minus-29_1-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1559521\" data-ts=\"1392068708\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WPX\" target=\"_blank\">WPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1559521-wpx-says-2013-results-hit-by-1_5b-in-writeoffs-reveals-1_47b-capex-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WPX says 2013 results hit by $1.5B in writeoffs, reveals $1.47B capex plan</a></h4><ul>     <li>WPX Energy (NYSE:<a href=\"https://seekingalpha.com/symbol/WPX\" title=\"WPX Energy, Inc.\">WPX</a>) <font color=\"red\">-6.1%</font> AH after saying its Q4 and FY 2013 financial results will include the impact of up to $1.B in pre-tax impairment charges, due to a decline in forward market natural gas prices, particularly in the Northeast, where Appalachia pricing declined 26% in Q4 and 34% overall during 2013.</li>\n<li>In a separate release, WPX reveals a 2014 capex plan of ~$1.47B, with ~85% of spending allocated  to Williston,  Piceance and San Juan Gallup development.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1559521\" data-linked=\"WPX says 2013 results hit by $1.5B in writeoffs, reveals $1.47B capex plan\" data-tweet=\"$WPX - WPX says 2013 results hit by $1.5B in writeoffs, reveals $1.47B capex plan https://seekingalpha.com/news/1559521-wpx-says-2013-results-hit-by-1_5b-in-writeoffs-reveals-1_47b-capex-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/1559521-wpx-says-2013-results-hit-by-1_5b-in-writeoffs-reveals-1_47b-capex-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1559461\" data-ts=\"1392067925\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JOEZ\" target=\"_blank\">JOEZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1559461-mill-road-with-stake-in-joes-jeans-may-go-activist\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mill Road with stake in Joe&#39;s Jeans; may go activist</a></h4><ul><li>Joe's Jeans (NASDAQ:<a href='https://seekingalpha.com/symbol/JOEZ' title='Joe&#39;s Jeans Inc.'>JOEZ</a>) is&nbsp;<font color='green'>ahead 5.6%</font>&nbsp;in after-hours trade as Mill Road Capital discloses a 5.1% stake in the company and says it may wish to \"engage\" with management.</li><li><a href=\"http://www.sec.gov/Archives/edgar/data/844143/000119312514043159/d673017dsc13d.htm\" target=\"_blank\">SEC Form 13G</a></li></ul><div class=\"tiny-share-widget\" data-id=\"1559461\" data-linked=\"Mill Road with stake in Joe&#39;s Jeans; may go activist\" data-tweet=\"$JOEZ - Mill Road with stake in Joe&#39;s Jeans; may go activist https://seekingalpha.com/news/1559461-mill-road-with-stake-in-joes-jeans-may-go-activist?source=tweet\" data-url=\"https://seekingalpha.com/news/1559461-mill-road-with-stake-in-joes-jeans-may-go-activist\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1559441\" data-ts=\"1392067841\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NMM\" target=\"_blank\">NMM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1559441-navios-partners-in-5_5m-unit-public-offering-minus-3_4-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Navios Partners in 5.5M-unit public offering, -3.4% AH</a></h4><ul>\n<li>Navios Maritime Partners (NYSE:<a href=\"https://seekingalpha.com/symbol/NMM\" title=\"Navios Maritime Partners L.P.\">NMM</a>) <font color=\"red\">-3.4%</font> AH on plans for a  public offering of 5.5M common units.</li>\n<li>NMM expects to use the proceeds to fund  its fleet expansion and/or for general partnership purposes.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1559441\" data-linked=\"Navios Partners in 5.5M-unit public offering, -3.4% AH\" data-tweet=\"$NMM - Navios Partners in 5.5M-unit public offering, -3.4% AH https://seekingalpha.com/news/1559441-navios-partners-in-5_5m-unit-public-offering-minus-3_4-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1559441-navios-partners-in-5_5m-unit-public-offering-minus-3_4-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1559401\" data-ts=\"1392067595\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WBMD\" target=\"_blank\">WBMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1559401-webmd-minus-2_8-percent-ah-after-pre-announcing-q4-results-issuing-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WebMD -2.8% AH after pre-announcing Q4 results, issuing guidance</a></h4><ul>\n<li>Ahead of a Tuesday Stifel conference talk, WebMD (NASDAQ:<a href=\"https://seekingalpha.com/symbol/WBMD\" title=\"WebMD Health Corp\">WBMD</a>) says it expects to report Q4 revenue of $145.5M-$146.5M and EPS of $0.23-$0.25, above a consensus of $144M and $0.17.</li>\n<li>The company is also guiding for Q1 revenue of $130M-$133M (above a $122.5M consensus), and 2014 revenue of $545M-$575M (in-line with a $565M consensus). Full-year net income is expected to total $27M-$29M, up from 2013's $14.3M-$15.1M.</li>\n<li>In addition, WebMD is adding $50M to its buyback program, raising its total available buyback funds to $70M. $211.3M was spent on buybacks in Q4.</li>\n<li>The company strikes a cautious tone about its early 2014 performance, stating \"the first five weeks of sales activity does not reflect year-on-year growth;\" the Q1 revenue consensus is for 8.6% growth.</li>\n<li>WebMD insists it doesn't think the weakness is reflective of a broader trend, and speculates it could partly be due to shifts in customer budgeting/buying patterns.</li>\n<li>Official Q4 results are due on Feb. 20.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1559401\" data-linked=\"WebMD -2.8% AH after pre-announcing Q4 results, issuing guidance\" data-tweet=\"$WBMD - WebMD -2.8% AH after pre-announcing Q4 results, issuing guidance https://seekingalpha.com/news/1559401-webmd-minus-2_8-percent-ah-after-pre-announcing-q4-results-issuing-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1559401-webmd-minus-2_8-percent-ah-after-pre-announcing-q4-results-issuing-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1559341\" data-ts=\"1392066951\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOH\" target=\"_blank\">MOH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1559341-molina-healthcare-inc-beats-by-0_49-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Molina Healthcare, Inc. beats by $0.49, misses on revenue</a></h4><ul>\n<li>Molina Healthcare, Inc. (NYSE:<a href=\"https://seekingalpha.com/symbol/MOH\" title=\"Molina Healthcare, Inc.\">MOH</a>): Q4 EPS of $0.44 <font color=\"green\">beats by $0.49</font>.</li>\n<li>Revenue of $1.71B (+8.2% Y/Y) <font color=\"red\">misses by $90M</font>.</li>\n<li>Shares <font color=\"green\">+3.8%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1559341\" data-linked=\"Molina Healthcare, Inc. beats by $0.49, misses on revenue\" data-tweet=\"$MOH - Molina Healthcare, Inc. beats by $0.49, misses on revenue https://seekingalpha.com/news/1559341-molina-healthcare-inc-beats-by-0_49-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1559341-molina-healthcare-inc-beats-by-0_49-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1559301\" data-ts=\"1392066773\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAX\" target=\"_blank\">RAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1559301-rackspace-ceo-retires-co-founder-chairman-to-act-as-interim-ceo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rackspace CEO retires; co-founder/chairman to act as interim CEO</a></h4><ul>\n<li>In tandem with its <a href=\"https://seekingalpha.com/news/1559231-rackspace-hosting-inc-eps-in-line-beats-on-revenue\" target=\"_blank\">Q4 results</a>, Rackspace (NYSE:<a href=\"https://seekingalpha.com/symbol/RAX\" title=\"Rackspace Hosting, Inc.\">RAX</a>) announces CEO Lanham Napier has retired from his position, and from the company's board. Co-founder/chairman Graham Weston will act as interim CEO while Rackspace searches for a permanent replacement.</li>\n<li>Napier will remain in a consulting role with Rackspace for the next few months. He now \"plans to invest in and advise other entrepreneurial companies.\"</li>\n<li>Weston previously served as Rackspace's CEO from 1999-2006. Napier has been running the show during Rackspace's entire history as a public company.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/RAX\" title=\"Rackspace Hosting, Inc.\">RAX</a> <font color=\"red\">-12.4%</font> AH.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1559301\" data-linked=\"Rackspace CEO retires; co-founder/chairman to act as interim CEO\" data-tweet=\"$RAX - Rackspace CEO retires; co-founder/chairman to act as interim CEO https://seekingalpha.com/news/1559301-rackspace-ceo-retires-co-founder-chairman-to-act-as-interim-ceo?source=tweet\" data-url=\"https://seekingalpha.com/news/1559301-rackspace-ceo-retires-co-founder-chairman-to-act-as-interim-ceo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1559191\" data-ts=\"1392065992\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GILD\" target=\"_blank\">GILD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1559191-gilead-plus-2_8-percent-on-positive-talk-sovaldi-would-make-numbers-look-even-better\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gilead +2.8% on positive talk, Sovaldi would make numbers look even better</a></h4><ul>     <li>Gilead Sciences (<a href=\"https://seekingalpha.com/symbol/GILD\" title=\"Gilead Sciences, Inc.\">GILD</a> <font color=\"green\">+2.8%</font>) continues its steady climb as Argus Research and Credit Suisse make positive calls on the hot pure-play biotech company.</li>     <li>Argus <a href=\"http://blogs.barrons.com/stockstowatchtoday/2014/02/10/gilead-sciences-sovaldi-exclusion-no-big-deal\" target=\"_blank\">raises its target price to $90</a> from $84 after posting <a href=\"https://seekingalpha.com/news/1548101-gilead-results-rise-on-improved-product-sales-easily-beating-estimates\" target=\"_blank\">strong Q4 sales growth</a>; GILD notably excluded any sales from Sovaldi even though it has been approved in the U.S., Canada and Europe, but the firm raised its 2014 EPS estimate to $3.35 from $3.25 and established a 2015 estimate of $5.10, including Sovaldi as well as ongoing growth from core pharmaceutical products.</li>\n<li>Credit Suisse <a href=\"http://247wallst.com/healthcare-business/2014/02/10/gilead-going-to-90-or-110/\" target=\"_blank\">ups its target to $100</a>, basing its prediction on 19.5x its 2015 earnings estimate and a 40% premium to the S&amp;P 500.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1559191\" data-linked=\"Gilead +2.8% on positive talk, Sovaldi would make numbers look even better\" data-tweet=\"$GILD - Gilead +2.8% on positive talk, Sovaldi would make numbers look even better https://seekingalpha.com/news/1559191-gilead-plus-2_8-percent-on-positive-talk-sovaldi-would-make-numbers-look-even-better?source=tweet\" data-url=\"https://seekingalpha.com/news/1559191-gilead-plus-2_8-percent-on-positive-talk-sovaldi-would-make-numbers-look-even-better\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1559181\" data-ts=\"1392065741\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKS\" target=\"_blank\">BKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1559181-barnes-and-noble-higher-after-reports-of-nook-job-cuts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barnes &amp; Noble higher after reports of Nook job cuts</a></h4><ul> <li>Shares of Barnes &amp; Noble (<a href='https://seekingalpha.com/symbol/BKS' title='Barnes & Noble Inc'>BKS</a> <font color='green'>+9.2%</font>)&nbsp;rose today after the company <a href=\"http://www.reuters.com/article/2014/02/10/us-barnesandnoble-nook-idUSBREA191TJ20140210\" target=\"_blank\">removed jobs</a> related to the Nook business.</li> <li>The amount of jobs removed at the company varies in different reports.</li> <li>Without being real specific, B&amp;N said it's \"rationalizing\" the Nook business.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1559181\" data-linked=\"Barnes &amp; Noble higher after reports of Nook job cuts\" data-tweet=\"$BKS - Barnes &amp; Noble higher after reports of Nook job cuts https://seekingalpha.com/news/1559181-barnes-and-noble-higher-after-reports-of-nook-job-cuts?source=tweet\" data-url=\"https://seekingalpha.com/news/1559181-barnes-and-noble-higher-after-reports-of-nook-job-cuts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1559161\" data-ts=\"1392064412\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DS\" target=\"_blank\">DS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1559161-new-media-flies-in-when-issued-trading\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Media flies in when-issued trading</a></h4><ul><li>In addition to a bit of excitement <a href=\"https://seekingalpha.com/news/1559141\" target=\"_blank\">around New Residential </a>this afternoon, another Newcastle Investment (NCT <font color='green'>+1.2%</font>) spinoff, New Media (NYSE:<a href='https://seekingalpha.com/symbol/NEWM' title='New Media'>NEWM</a>) began when-issued trading last week at $11 per share and is up to $14.05. The actual <a href=\"https://seekingalpha.com/news/1529461-newcastle-sets-new-media-distribution\" target=\"_blank\">spinoff date is February 13</a>.</li><li>To review: Newcastle owners get 0.07219 shares of New Media for each share of Newcastle they own.</li><li><a href=\"http://www.sec.gov/Archives/edgar/data/1579684/000119312514024018/d639494ds1a.htm\" target=\"_blank\">New Media S-1</a></li></ul><div class=\"tiny-share-widget\" data-id=\"1559161\" data-linked=\"New Media flies in when-issued trading\" data-tweet=\"$DS $DS $NEWM - New Media flies in when-issued trading https://seekingalpha.com/news/1559161-new-media-flies-in-when-issued-trading?source=tweet\" data-url=\"https://seekingalpha.com/news/1559161-new-media-flies-in-when-issued-trading\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1559151\" data-ts=\"1392064155\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORMP\" target=\"_blank\">ORMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1559151-oramed-submits-phase-2a-protocol-to-fda-for-diabetes-treatment-plus-14-percent\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oramed submits phase 2a protocol to FDA for diabetes treatment, +14%</a></h4><ul>     <li>Oramed Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ORMP\" title=\"Oramed Pharmaceuticals Inc.\">ORMP</a> <font color=\"green\">+13.9%</font>) says it delivered to the FDA the protocol for phase 2a testing of its oral insulin capsule treating both Type 1 and Type 2 diabetes.</li>     <li>The protocol was submitted under ORMP's existing investigational new drug application for its ORMD-0801 drug candidate; the double-blind, placebo controlled study, expected to start next month, will be carried out over seven days at an in-patient facility with 24 Type 1 diabetic patients.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1559151\" data-linked=\"Oramed submits phase 2a protocol to FDA for diabetes treatment, +14%\" data-tweet=\"$ORMP - Oramed submits phase 2a protocol to FDA for diabetes treatment, +14% https://seekingalpha.com/news/1559151-oramed-submits-phase-2a-protocol-to-fda-for-diabetes-treatment-plus-14-percent?source=tweet\" data-url=\"https://seekingalpha.com/news/1559151-oramed-submits-phase-2a-protocol-to-fda-for-diabetes-treatment-plus-14-percent\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1559141\" data-ts=\"1392063492\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NRZ\" target=\"_blank\">NRZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1559141-cooperman-discloses-6-percent-stake-in-nrz\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cooperman discloses 6% stake in NRZ</a></h4><ul><li>New Residential (<a href='https://seekingalpha.com/symbol/NRZ' title='New Residential Investment Corp.'>NRZ</a> <font color='green'>+0.3%</font>) quickly eliminates a loss on the session and turns higher as Lee Cooperman <a href=\"http://www.sec.gov/Archives/edgar/data/898382/000117152014000133/eps5503.htm\" target=\"_blank\">discloses a 6% stake</a> in the Newcastle Investment (NCT <font color='green'>+1.2%</font>) spinoff.</li></ul><div class=\"tiny-share-widget\" data-id=\"1559141\" data-linked=\"Cooperman discloses 6% stake in NRZ\" data-tweet=\"$NRZ $NRZ $DS - Cooperman discloses 6% stake in NRZ https://seekingalpha.com/news/1559141-cooperman-discloses-6-percent-stake-in-nrz?source=tweet\" data-url=\"https://seekingalpha.com/news/1559141-cooperman-discloses-6-percent-stake-in-nrz\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1559111\" data-ts=\"1392062809\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1559111-tesla-motors-knocking-on-200-per-share-door\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla Motors knocking on $200-per-share door</a></h4><ul> <li>Shares of Tesla Motors (<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a> <font color='green'>+5.8%</font>) set a new record at $199.30 in intraday trading as more <a href=\"http://www.schaeffersresearch.com/marketcenters/optionscenter/content/tesla+motors+inc+tsla+record+high+triggers+bullish+betting/default.aspx?ID=119728\" target=\"_blank\">bullish bets</a> come pouring in.</li> <li>Call action today is 55% above normal activity.</li> <li>There isn't any concrete news of note on Tesla, today's strength is based on a large part on momentum.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1559111\" data-linked=\"Tesla Motors knocking on $200-per-share door\" data-tweet=\"$TSLA - Tesla Motors knocking on $200-per-share door https://seekingalpha.com/news/1559111-tesla-motors-knocking-on-200-per-share-door?source=tweet\" data-url=\"https://seekingalpha.com/news/1559111-tesla-motors-knocking-on-200-per-share-door\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1559051\" data-ts=\"1392061150\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCJ\" target=\"_blank\">CCJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1559051-cameco-minus-4-percent-as-weak-uranium-outlook-causes-pullback-in-production-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cameco -4% as weak uranium outlook causes pullback in production target</a></h4><ul>     <li>Cameco (<a href=\"https://seekingalpha.com/symbol/CCJ\" title=\"Cameco Corporation\">CCJ</a> <font color=\"red\">-3.9%</font>) slumps as <a href=\"https://seekingalpha.com/news/1557311-cameco-corporation-eps-of-c-0_38\" target=\"_blank\">Q4 sales volumes slipped 12%</a> despite producing a record amount of uranium in the quarter, 15% higher than the same period last year.</li>     <li>CCJ also says it is moving away from its production target of 36M lbd. by 2018, citing uncertainty in the uranium market which has lasted longer than the company expected; despite an extensive portfolio of assets that could boost production in the future, CCJ says it won't push its production growth as aggressively as before.</li>     <li>Expects 2014 revenue to rise 5% due to increased realized prices for uranium; sees 35%-40% lower exploration expenses, citing decreased activities in Australia and a reorganized global exploration portfolio which will focus on core projects in Saskatchewan.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/NLR\" title=\"VanEck Vectors Uranium+Nuclear Energy ETF\">NLR</a>, <a href=\"https://seekingalpha.com/symbol/NUCL\" title=\"iShares S&amp;P Global Nuclear Energy Index ETF\">NUCL</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1559051\" data-linked=\"Cameco -4% as weak uranium outlook causes pullback in production target\" data-tweet=\"$CCJ $CCJ $NLR - Cameco -4% as weak uranium outlook causes pullback in production target https://seekingalpha.com/news/1559051-cameco-minus-4-percent-as-weak-uranium-outlook-causes-pullback-in-production-target?source=tweet\" data-url=\"https://seekingalpha.com/news/1559051-cameco-minus-4-percent-as-weak-uranium-outlook-causes-pullback-in-production-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1559031\" data-ts=\"1392060739\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CALL\" target=\"_blank\">CALL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1559031-magicjack-soars-after-tilson-pounds-the-table\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">magicJack soars after Tilson pounds the table</a></h4><ul>\n<li>In a report (<a href=\"https://seekingalpha.com/article/1431891-the-whitney-tilson-indicator-time-to-short-netflix\" target=\"_blank\">unironically</a>) titled \"<a href=\"http://ify.valuewalk.com/wp-content/uploads/2014/02/MagicJack-My-Next-Netflix-Whitney-Tilson-2-7-14.pdf\" target=\"_blank\">magicJack: My Next Netflix</a>,\" Whitney Tilson praises magicJack's (<a href=\"https://seekingalpha.com/symbol/CALL\" title=\"magicJack VocalTec Communications Ltd.\">CALL</a> <font color=\"green\">+14.2%</font>) low valuation (5.6x trailing EPS), huge short interest (43% of the float), recent <a href=\"https://seekingalpha.com/news/1468631-magicjack-hires-coo\" target=\"_blank\">management shakeu</a>p, and large market opportunity (70M U.S. households with wireline phone service + international users looking to make cheap U.S. calls).</li>\n<li>Tilson, whose firm recently disclosed a 164K-share magicJack position, also talks up the VoIP service provider's strong value proposition (its service costs $30/year, or $2.50/month), strong margins (66% gross margin over the first 9 months of 2013), and low cost per gross add (in the $4-$5 range).</li>\n<li>He expects management's efforts to clean up magicJack's marketing efforts - the company's old marketing is compared to \"cheesy late-night infomercials\" - to pay off, and a new marketing push to yield \"rapid subscriber growth.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1559031\" data-linked=\"magicJack soars after Tilson pounds the table\" data-tweet=\"$CALL - magicJack soars after Tilson pounds the table https://seekingalpha.com/news/1559031-magicjack-soars-after-tilson-pounds-the-table?source=tweet\" data-url=\"https://seekingalpha.com/news/1559031-magicjack-soars-after-tilson-pounds-the-table\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1559021\" data-ts=\"1392059950\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARNA\" target=\"_blank\">ARNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1559021-arena-pharma-plus-5-percent-on-broader-coverage-for-belviq\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arena Pharma +5% on broader coverage for Belviq</a></h4><ul>     <li>Arena Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ARNA\" title=\"Arena Pharmaceuticals, Inc.\">ARNA</a> <font color=\"green\">+4.9%</font>) and Japanese partner say their Belviq weight loss drug will be available to more people thanks to an agreement with pharmacy benefits manager CVS Caremark (<a href=\"https://seekingalpha.com/symbol/CVS\" title=\"CVS Health Corporation\">CVS</a> <font color=\"green\">+0.6%</font>), which means more than half of all Americans with insurance should now have access to the drug.</li>\n<li>Aetna (NYSE:<a href=\"https://seekingalpha.com/symbol/AET\" title=\"Aetna, Inc.\">AET</a>) recently announced it would offer Belviq as a preferred brand  to eligible patients as part of its pilot program to self-insured plan  sponsors.</li>     <li>Belviq is approved for use in adults who are obese or who are overweight  and have at least one serious medical condition, such as diabetes or  high cholesterol.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1559021\" data-linked=\"Arena Pharma +5% on broader coverage for Belviq\" data-tweet=\"$ARNA $ARNA $CVS - Arena Pharma +5% on broader coverage for Belviq https://seekingalpha.com/news/1559021-arena-pharma-plus-5-percent-on-broader-coverage-for-belviq?source=tweet\" data-url=\"https://seekingalpha.com/news/1559021-arena-pharma-plus-5-percent-on-broader-coverage-for-belviq\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558941\" data-ts=\"1392056875\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RVLT\" target=\"_blank\">RVLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558941-revolution-lighting-jumps-after-providing-q4-numbers-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Revolution Lighting jumps after providing Q4 numbers, guidance</a></h4><ul>\n<li>In a business update, Revolution Lighting (<a href=\"https://seekingalpha.com/symbol/RVLT\" title=\"Revolution Lighting Technologies, Inc.\">RVLT</a> <font color=\"green\">+7.7%</font>) says it expects to report Q4 revenue of $7M (+600% Y/Y, or +100% exc. acquisitions). That's less than a prior forecast of $10M, something the LED lighting system vendor blames on the delay of a major international order.</li>\n<li>More importantly, Revolution is forecasting 2014 revenue of $50M (50%+ organic revenue growth), and says it has a pipeline of \"close to $200 million in actionable opportunities over the next 12 to 18 months.\"</li>\n<li>2014 gross margin is expected to be at 35% or higher. That's compares with a <a href=\"https://seekingalpha.com/news/1400782-revolution-lighting-blasts-off-following-q3-results-q4-guidance\" target=\"_blank\">Q3 level</a> of 26%, and a Q2 level of 49%.</li>\n<li>Revolution's full Q4 results arrive on March 13.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1558941\" data-linked=\"Revolution Lighting jumps after providing Q4 numbers, guidance\" data-tweet=\"$RVLT - Revolution Lighting jumps after providing Q4 numbers, guidance https://seekingalpha.com/news/1558941-revolution-lighting-jumps-after-providing-q4-numbers-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1558941-revolution-lighting-jumps-after-providing-q4-numbers-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558891\" data-ts=\"1392055147\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALXN\" target=\"_blank\">ALXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558891-alexion-pharma-plus-3_9-percent-as-deutsche-bank-lifts-target-price-to-205\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alexion Pharma +3.9% as Deutsche Bank lifts target price to $205</a></h4><ul>     <li>Alexion Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ALXN\" title=\"Alexion Pharmaceuticals, Inc.\">ALXN</a> <font color=\"green\">+3.9%</font>) moves higher after Deutsche Bank <a href=\"http://www.streetinsider.com/Analyst+Comments/Alexion+%28ALXN%29+Price+Target+Raised+to+%24205+at+Deutsche+Bank+on+HPP+Market+Opp/9144135.html\" target=\"_blank\">raises its price target</a> on the stock to $205 from $125, believing the market for Asfotase Alfa for severe  hypophosphatasia is larger than Wall Street expectations.</li>\n<li>The firm sees a ~$1.6B opportunity for Asfotase Alfa, and given the patient mix, it thinks its assumptions could be  conservative in its assumption that the blended average price per patient  over time is ~$200K since it is below Myozyme ($600K) pricing.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1558891\" data-linked=\"Alexion Pharma +3.9% as Deutsche Bank lifts target price to $205\" data-tweet=\"$ALXN - Alexion Pharma +3.9% as Deutsche Bank lifts target price to $205 https://seekingalpha.com/news/1558891-alexion-pharma-plus-3_9-percent-as-deutsche-bank-lifts-target-price-to-205?source=tweet\" data-url=\"https://seekingalpha.com/news/1558891-alexion-pharma-plus-3_9-percent-as-deutsche-bank-lifts-target-price-to-205\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558871\" data-ts=\"1392054350\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558871-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>\n<li>\n<b>Top 10 Gainers:</b> <a href=\"https://seekingalpha.com/symbol/SUPX\" title=\"Supertex, Inc.\">SUPX</a> <font color=\"green\">+35%</font>. <a href=\"https://seekingalpha.com/symbol/HWG\" title=\"The Hallwood Group Incorporated\">HWG</a> <font color=\"green\">+28%</font>. YOD <font color=\"green\">+26%</font>. <a href=\"https://seekingalpha.com/symbol/AZC\" title=\"Augusta Resource Corporation\">AZC</a> <font color=\"green\">+25%</font>. <a href=\"https://seekingalpha.com/symbol/AMAP\" title=\"AutoNavi Holdings\">AMAP</a> <font color=\"green\">+25%</font>. IOT <font color=\"green\">+24%</font>. <a href=\"https://seekingalpha.com/symbol/ARL\" title=\"American Realty Investors, Inc.\">ARL</a> <font color=\"green\">+22%</font>. IFON <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/EDGW\" title=\"Edgewater Technology, Inc.\">EDGW</a> <font color=\"green\">+19%</font>. <a href=\"https://seekingalpha.com/symbol/PLUG\" title=\"Plug Power, Inc.\">PLUG</a> <font color=\"green\">+18%</font>.</li>\n<li>\n<b>Top 10 Losers:</b> <a href=\"https://seekingalpha.com/symbol/BWP\" title=\"Boardwalk Pipeline Partners, LP\">BWP</a> <font color=\"red\">-39%</font>. <a href=\"https://seekingalpha.com/symbol/PRAN\" title=\"Prana Biotechnology Ltd\">PRAN</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/CYOU\" title=\"Changyou.com Limited\">CYOU</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/BID\" title=\"Sotheby's\">BID</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/VSR\" title=\"Versar, Inc\">VSR</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/LPHI\" title=\"Life Partners Holdings Inc\">LPHI</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/MTSN\" title=\"Mattson Technology, Inc.\">MTSN</a> <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/ELON\" title=\"Echelon Corporation\">ELON</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/NKA\" title=\"Niska Gas Storage Partners LLC\">NKA</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/UWN\" title=\"Nevada Gold &amp; Casinos, Inc\">UWN</a> <font color=\"red\">-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1558871\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$SUPX $HWG $SSC-OLD - Midday Gainers / Losers https://seekingalpha.com/news/1558871-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1558871-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558861\" data-ts=\"1392054292\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSC-OLD\" target=\"_blank\">SSC-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558861-you-on-demand-soars-following-bullish-sa-column\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">You On Demand soars following bullish SA column</a></h4><ul>\n<li>SA contributor/hedge fund analyst <a href=\"https://seekingalpha.com/article/2004371-you-on-demand-the-netflix-of-china\" target=\"_blank\">Always Incredulous</a> observes You On Demand (YOD <font color=\"green\">+38.1%</font>) has an exclusive Chinese nationwide license for distributing pay-per-view/VOD content (covers 19.7M cable/IPTV households), and has deals in place with top U.S. studios such as <a href=\"https://seekingalpha.com/news/1537781-disney-titles-go-to-you-on-demand\" target=\"_blank\">Disney</a>, Paramount, Miramax, and Warner Bros.</li>\n<li>The author likes YOD's willingness to price its offerings competitively with pirated DVDs, sees the company benefiting from Chinese cable and mobile video adoption - YOD has an app pre-install deal with Huawei, and is talking with other smartphone OEMs - and expects a $19M investment from Taiwanese hardware firm C-Media will give YOD plenty of time to turn profitable.</li>\n<li>Shares have soared to new 52-week highs. YOD's market cap currently stands at $70M.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1558861\" data-linked=\"You On Demand soars following bullish SA column\" data-tweet=\"$SSC-OLD - You On Demand soars following bullish SA column https://seekingalpha.com/news/1558861-you-on-demand-soars-following-bullish-sa-column?source=tweet\" data-url=\"https://seekingalpha.com/news/1558861-you-on-demand-soars-following-bullish-sa-column\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558841\" data-ts=\"1392053651\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ICPT\" target=\"_blank\">ICPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558841-intercept-pharma-plus-9-percent-as-wedbush-morgan-raises-price-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intercept Pharma +9% as Wedbush Morgan raises price target</a></h4><ul>     <li>Intercept Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ICPT\" title=\"Intercept Pharmaceuticals\">ICPT</a> <font color=\"green\">+8.9%</font>) rises after Wedbush Morgan <a href=\"http://www.streetinsider.com/Analyst+Comments/Intercept+Pharmaceuticals+%28ICPT%29+Price+Target+Raised+to+%24493+at+Wedbush/9143764.html\" target=\"_blank\">hikes its target price on the shares to $493</a>, projecting gross annual peak sales of the company's OCA (obeticholic acid) treatment for alcoholic hepatitis could surpass $3B worldwide.</li>     <li>ICPT is supporting a phase 2 trial treating 60 patients with alcoholic hepatitis beginning in March; prevalence estimates for AH are 10%-35% of alcoholics, or 2.4M-8.4M U.S. patients.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1558841\" data-linked=\"Intercept Pharma +9% as Wedbush Morgan raises price target\" data-tweet=\"$ICPT - Intercept Pharma +9% as Wedbush Morgan raises price target https://seekingalpha.com/news/1558841-intercept-pharma-plus-9-percent-as-wedbush-morgan-raises-price-target?source=tweet\" data-url=\"https://seekingalpha.com/news/1558841-intercept-pharma-plus-9-percent-as-wedbush-morgan-raises-price-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558761\" data-ts=\"1392051521\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTI\" target=\"_blank\">TTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558761-tetra-technologies-offers-weak-q4-fy-2014-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tetra Technologies offers weak Q4, FY 2014 outlook</a></h4><ul>     <li>Tetra Technologies (<a href=\"https://seekingalpha.com/symbol/TTI\" title=\"Tetra Technologies Inc.\">TTI</a> <font color=\"red\">-4.2%</font>) issues downside guidance on its Q4 2013 and FY 2014 earnings, pointing to continued weakness in its North American testing operations after the segment's revenue dropped 63% in Q3.</li>     <li>The oil and gas services company sees Q4 EPS of $0.10-$0.12 vs. $0.17 analyst consensus estimate; for 2014, it expects EPS of $0.80-$0.90 vs. $0.92 consensus.</li>     <li>TTI says it has taken aggressive costs reduction actions and expanded its sales capabilities in hopes of improving results.</li>     <li>TTI also says it acquired the assets of water management services company WIT Water Transfer; financial terms were not disclosed.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1558761\" data-linked=\"Tetra Technologies offers weak Q4, FY 2014 outlook\" data-tweet=\"$TTI - Tetra Technologies offers weak Q4, FY 2014 outlook https://seekingalpha.com/news/1558761-tetra-technologies-offers-weak-q4-fy-2014-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/1558761-tetra-technologies-offers-weak-q4-fy-2014-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558751\" data-ts=\"1392050674\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AOL\" target=\"_blank\">AOL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558751-aol-slides-amid-distressed-babies-backlash\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AOL slides amid &quot;distressed babies&quot; backlash</a></h4><ul><li>AOL (<a href='https://seekingalpha.com/symbol/AOL' title='AOL Inc.'>AOL</a> <font color='red'>-3.3%</font>) is selling off after CEO Tim Armstrong <a href=\"http://www.usatoday.com/story/money/business/2014/02/09/aol-ceo-comment-backfire/5343349/\" target=\"_blank\">triggered an employee backlash</a> and <a href=\"https://www.google.com/search?hl=en&amp;gl=us&amp;tbm=nws&amp;authuser=0&amp;q=aol+distressed&amp;oq=aol+distressed&amp;gs_l=news-cc.3..43j43i53.1090.3272.0.3400.14.2.0.12.12.0.65.124.2.2.0...0.0...1ac.1.wr9NZtdaM0Y#authuser=0&amp;gl=us&amp;hl=en&amp;q=aol+tim+armstrong&amp;tbm=nws\" target=\"_blank\">media firestorm</a> by delaying his company's matching 401(k) contributions to the end of each calendar year, and blaming it in part on high health care costs for two \"distressed babies\" born to employee families.</li><li>Armstrong has backtracked on the 401(k) change and apologized for his remarks. The controversy arrives just six months after Armstrong was <a href=\"http://techcrunch.com/2013/08/13/aol-ceo-tim-armstrong-apologizes-for-brutally-firing-employee-during-patch-all-hands-call/\" target=\"_blank\">forced to apologize</a> for firing a Patch employee on the spot for taking video of a layoff announcement.</li><li>AOL sold off last Thursday following its Q4 report. Though the company <a href=\"https://seekingalpha.com/news/1552331-aol-inc-beats-by-0_02-beats-on-revenue\" target=\"_blank\">beat estimates</a>, it also reported a 2% Y/Y drop in search ad revenue (3% growth was seen in Q3), and a 10% drop in subscription (dial-up ISP) revenue. BofA/Merrill and Macquarie cut shares to Neutral on Friday; the former <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/14/02/4291229/update-bank-of-america-downgrades-aol-noting-disappointi\" target=\"_blank\">cited</a> a disappointing EBITDA forecast.</li></ul><div class=\"tiny-share-widget\" data-id=\"1558751\" data-linked=\"AOL slides amid &quot;distressed babies&quot; backlash\" data-tweet=\"$AOL - AOL slides amid &quot;distressed babies&quot; backlash https://seekingalpha.com/news/1558751-aol-slides-amid-distressed-babies-backlash?source=tweet\" data-url=\"https://seekingalpha.com/news/1558751-aol-slides-amid-distressed-babies-backlash\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558741\" data-ts=\"1392050673\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDCO\" target=\"_blank\">MDCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558741-analyst-cangrelor-a-failure-even-if-approved\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analyst: Cangrelor a failure even if approved</a></h4><ul>\n<li>The Medicines Company (<a href=\"https://seekingalpha.com/symbol/MDCO\" title=\"The Medicines Company\">MDCO</a> <font color=\"red\">-5.8%</font>) is under pressure after <a href=\"https://seekingalpha.com/news/1558181\" target=\"_blank\">negative comments</a> from the FDA ahead of this week's adcomm on Cangrelor, but Summer Street's Bart Classen says the drug <a href=\"http://www.streetinsider.com/Analyst+Comments/Cangrelo+Will+be+Commercial+Failure+Even+if+FDA+Approved+-+Analyst+%28MDCO%29/9144406.html\" target=\"_blank\">will be a commercial failure</a> even if approved.</li>\n<li>\"The FDA, like our experts, had criticized the pivotal Phoenix trial because Plavix was given too late in the control group to optimize its benefit,\" writes Classen. \"The product will be much more expensive than comparable agents with no superiority in efficacy or safety.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1558741\" data-linked=\"Analyst: Cangrelor a failure even if approved\" data-tweet=\"$MDCO - Analyst: Cangrelor a failure even if approved https://seekingalpha.com/news/1558741-analyst-cangrelor-a-failure-even-if-approved?source=tweet\" data-url=\"https://seekingalpha.com/news/1558741-analyst-cangrelor-a-failure-even-if-approved\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558681\" data-ts=\"1392049904\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRAN\" target=\"_blank\">PRAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558681-prana-biotech-minus-13-percent-as-analyst-casts-doubt-on-pbt2-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Prana Biotech -13% as analyst casts doubt on PBT2 data</a></h4><ul>     <li>Prana Biotechnology (<a href=\"https://seekingalpha.com/symbol/PRAN\" title=\"Prana Biotechnology Ltd\">PRAN</a> <font color=\"red\">-13.2%</font>) plunges following <a href=\"http://www.streetinsider.com/Analyst+Comments/Prana+Biotechnology+%28PRAN%29+Stock+Declines%3B+Summer+Street+Not+Impressed+with+PBT2+Data/9143729.html\" target=\"_blank\">negative comments</a> from Sumner Street analyst Bart Classen, who isn't impressed with data from PRAN's <a href=\"https://seekingalpha.com/news/1453621-prana-soars-as-treatment-phase-completed-in-alzheimers-trial\" target=\"_blank\">PBT2 treatment</a> for Alzheimer's and Huntington\u2019s diseases.</li>\n<li>Although a 12-week trial showed improvement in some components of the  neuropsychological test battery, the firm believes the results  are not statistically significant when one adjusts for using multiple  endpoints and is skeptical that the  results will add clarity to the question of  efficacy in Alzheimer's patients.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1558681\" data-linked=\"Prana Biotech -13% as analyst casts doubt on PBT2 data\" data-tweet=\"$PRAN $ATHE - Prana Biotech -13% as analyst casts doubt on PBT2 data https://seekingalpha.com/news/1558681-prana-biotech-minus-13-percent-as-analyst-casts-doubt-on-pbt2-data?source=tweet\" data-url=\"https://seekingalpha.com/news/1558681-prana-biotech-minus-13-percent-as-analyst-casts-doubt-on-pbt2-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558661\" data-ts=\"1392049183\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STJ\" target=\"_blank\">STJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558661-st-jude-plus-3_2-percent-as-sell-side-love-bursts-through\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">St. Jude +3.2% as sell-side love bursts through</a></h4><ul>     <li>St. Jude Medical (<a href=\"https://seekingalpha.com/symbol/STJ\" title=\"St. Jude Medical, Inc.\">STJ</a> <font color=\"green\">+3.2%</font>) enjoys lots of positive chatter following Friday's analyst day.</li>     <li>Stifel <a href=\"http://finance.yahoo.com/news/ahead-bell-analyst-raises-st-135621719.html\" target=\"_blank\">upgrades shares to Buy</a> from Hold with a $75 price target, touting the company's pipeline that spans several businesses and targets new and existing markets; the firm is convinced STJ is poised to show steadily accelerating sales  growth and expanding margins during the next 2-3 years, yielding above consensus top- and-bottom line numbers in the process.</li>     <li>Morgan Stanley says end-market stability and pipeline catalysts into H2 2014 suggest <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/14/02/4295042/morgan-stanley-sees-st-jude-medical-as-poised-for-accele\" target=\"_blank\">acceleration</a> across the next several quarters; it reiterates an Overweight rating and $75 target.</li>     <li>BofA is out positive too, calling the stock a \"<a href=\"https://twitter.com/thenotablecalls/status/432896235415293952\" target=\"_blank\">best idea</a>\" and seeing several potential catalysts through the rest of 2014; the firm tags an $80 target price.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1558661\" data-linked=\"St. Jude +3.2% as sell-side love bursts through\" data-tweet=\"$STJ - St. Jude +3.2% as sell-side love bursts through https://seekingalpha.com/news/1558661-st-jude-plus-3_2-percent-as-sell-side-love-bursts-through?source=tweet\" data-url=\"https://seekingalpha.com/news/1558661-st-jude-plus-3_2-percent-as-sell-side-love-bursts-through\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558651\" data-ts=\"1392049027\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558651-gold-continues-2014-run-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold continues 2014 run higher</a></h4><ul>\n<li>\n<font color=\"green\">Up another 1%</font> this morning, gold takes out a new high for the year at $1,275 per ounce (about 6% higher than it started 2014). A possible catalyst today is <a href=\"http://www.marketwatch.com/story/gold-extends-last-weeks-winning-streak-2014-02-10?link=MW_story_latest_news\" target=\"_blank\">the reopening</a> of China's markets after having been closed since January 31 for the Lunar New Year.</li>\n<li>Looking ahead, there's tomorrow's Congressional testimony from Janet Yellen - her first appearance in front of lawmakers since taking the Fed reins from Ben Bernanke. Plenty of weak macro data has boosted the yellow metal this year, but look for a quick retreat if Yellen is more upbeat about growth than the recent (maybe weather-related) numbers suggest.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/gld\" title=\"SPDR Gold Trust ETF\">GLD</a> <font color=\"green\">+0.6%</font>, <a href=\"https://seekingalpha.com/symbol/iau\" title=\"iShares Gold Trust ETF\">IAU</a> <font color=\"green\">+0.6%</font>.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/gld\" title=\"SPDR Gold Trust ETF\">GLD</a>, <a href=\"https://seekingalpha.com/symbol/iau\" title=\"iShares Gold Trust ETF\">IAU</a>, <a href=\"https://seekingalpha.com/symbol/phys\" title=\"Sprott Physical Gold Trust\">PHYS</a>, <a href=\"https://seekingalpha.com/symbol/sgol\" title=\"ETFS Physical Swiss Gold Trust ETF\">SGOL</a>, <a href=\"https://seekingalpha.com/symbol/ugl\" title=\"ProShares Ultra Gold ETF\">UGL</a>, <a href=\"https://seekingalpha.com/symbol/dgp\" title=\"PowerShares DB Gold Double Long ETN\">DGP</a>, <a href=\"https://seekingalpha.com/symbol/gll\" title=\"ProShares UltraShort Gold ETF\">GLL</a>, <a href=\"https://seekingalpha.com/symbol/dzz\" title=\"PowerShares DB Gold Double Short ETN\">DZZ</a>, <a href=\"https://seekingalpha.com/symbol/ugld\" title=\"VelocityShares 3x Long Gold ETN\">UGLD</a>, <a href=\"https://seekingalpha.com/symbol/dgl\" title=\"PowerShares DB Gold ETF\">DGL</a>, <a href=\"https://seekingalpha.com/symbol/dgz\" title=\"PowerShares DB Gold Short ETN\">DGZ</a>, <a href=\"https://seekingalpha.com/symbol/agol\" title=\"ETFS Physical Asian Gold Shares Trust ETF\">AGOL</a>, <a href=\"https://seekingalpha.com/symbol/gldi\" title=\"Credit Suisse Gold Shares Covered Call ETN\">GLDI</a>, <a href=\"https://seekingalpha.com/symbol/dgld\" title=\"VelocityShares 3x Inverse Gold ETN\">DGLD</a>, <a href=\"https://seekingalpha.com/symbol/tbar\" title=\"RBS Gold Trendpilot ETN\">TBAR</a>, <a href=\"https://seekingalpha.com/symbol/ubg\" title=\"UBS ETRACS CMCI Gold Total Return ETN\">UBG</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1558651\" data-linked=\"Gold continues 2014 run higher\" data-tweet=\"$GLD $IAU $PHYS - Gold continues 2014 run higher https://seekingalpha.com/news/1558651-gold-continues-2014-run-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/1558651-gold-continues-2014-run-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558641\" data-ts=\"1392048975\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGSE\" target=\"_blank\">RGSE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558641-rgs-energy-surges-on-cowen-pt-hike\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RGS Energy surges on Cowen PT hike</a></h4><ul>\n<li>Cowen's <a href=\"http://www.streetinsider.com/Analyst+Comments/Cowen+Boosts+PT+on+Real+Goods+Solar+%28RSOL%29+to+%245%3B+Recent+Project+Addtions+Improve+Outlook/9143401.html\" target=\"_blank\">Robert Stone</a> has raised his RGS Energy (RSOL <font color=\"green\">+6.4%</font>) PT to $5 from $3.50, while reiterating an Outperform.</li>\n<li>Stone is upbeat about RGS' recent <a href=\"https://seekingalpha.com/currents/post/1485191\" target=\"_blank\">Vermont</a> and <a href=\"https://seekingalpha.com/news/1490461-real-goods-solar-strikes-massachusetts-deal-shares-plus-12_2-percent-premarket\" target=\"_blank\">Massachusetts</a> solar project deals, and notes the projects (total capacity of 8MW) collectively equal 40% of his 2014 commercial installation forecast of 20.1MW.</li>\n<li>Stone has lowered his Q4 and Q1 EPS forecasts to -$0.06 apiece.</li>\n<li>\n<a href=\"https://seekingalpha.com/news/1547271-rgs-energy-jumps-after-announcing-150m-jv\" target=\"_blank\">Previous:</a> RGS Energy jumps after announcing $150M JV</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1558641\" data-linked=\"RGS Energy surges on Cowen PT hike\" data-tweet=\"$RGSE - RGS Energy surges on Cowen PT hike https://seekingalpha.com/news/1558641-rgs-energy-surges-on-cowen-pt-hike?source=tweet\" data-url=\"https://seekingalpha.com/news/1558641-rgs-energy-surges-on-cowen-pt-hike\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558631\" data-ts=\"1392048317\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RRGB\" target=\"_blank\">RRGB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558631-investment-firms-turn-bullish-on-red-robin-gourmet-burgers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investment firms turn bullish on Red Robin Gourmet Burgers</a></h4><ul>     <li>Shares of Red Robin Gourmet Burgers (<a href=\"https://seekingalpha.com/symbol/RRGB\" title=\"Red Robin Gourmet Burgers, Inc.\">RRGB</a> <font color=\"green\">+8.6%</font>) swing higher after a pair of investment firms come in with upgrades.</li>     <li>Raymond James moves to <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/14/02/4295477/update-raymond-james-upgrades-red-robin-gourmet-burgers-\" target=\"_blank\">Strong Buy</a> from Outperform on its view that a compelling risk/reward profile exists on the restaurant operator.</li>     <li>Bank of America has RRGB set as a <a href=\"http://www.analystratings.net/stocks/NASDAQ/RRGB/\" target=\"_blank\">Buy</a> after having it tagged with an Underperform rating previously.</li>     <li>There is a general feeling in the casual dining sector that big changes (store closures, spinoffs, M&amp;A) are in the works with traffic trends soft.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1558631\" data-linked=\"Investment firms turn bullish on Red Robin Gourmet Burgers\" data-tweet=\"$RRGB - Investment firms turn bullish on Red Robin Gourmet Burgers https://seekingalpha.com/news/1558631-investment-firms-turn-bullish-on-red-robin-gourmet-burgers?source=tweet\" data-url=\"https://seekingalpha.com/news/1558631-investment-firms-turn-bullish-on-red-robin-gourmet-burgers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558591\" data-ts=\"1392047625\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FUEL\" target=\"_blank\">FUEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558591-rocket-fuel-jumps-on-goldman-coverage-launch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rocket Fuel jumps on Goldman coverage launch</a></h4><ul>\n<li>Goldman's <a href=\"http://www.streetinsider.com/New+Coverage/Goldman+Sachs+Starts+Rocket+Fuel+%28FUEL%29+at+Buy%2C+%2469+PT/9142607.html\" target=\"_blank\">Debra Schawartz</a> has started coverage on Rocket Fuel (<a href=\"https://seekingalpha.com/symbol/FUEL\" title=\"Rocket Fuel\">FUEL</a> <font color=\"green\">+7.7%</font>) with a Buy and $69 PT.</li>\n<li>She declares the adoption of <a href=\"http://www.adexchanger.com/online-advertising/define-programmatic-buying/\" target=\"_blank\">programmatic ad-buying</a> solutions such as Rocket Fuel's \"one of the more significant undercurrents shaping the online advertising landscape in 2014,\" and thinks higher penetration rates and new sales channels will drive the company's estimates higher in spite of intense competition.</li>\n<li>\n<a href=\"http://www.emarketer.com/Article/Programmatic-Ad-Spend-Set-Soar/1010343\" target=\"_blank\">eMarketer has forecast</a> global programmatic display ad sales will grow 38% in 2014 to $16.6B, after growing 58% in 2013. Real-time bidding (RTB) solutions such as Rocket Fuel's have been steadily growing their share of programmatic ad spend.</li>\n<li>Criteo (<a href=\"https://seekingalpha.com/symbol/CRTO\" title=\"Criteo S.A.\">CRTO</a> <font color=\"green\">+0.1%</font>) <a href=\"http://www.criteo.com/en/programmatic-buying\" target=\"_blank\">also competes</a> in the programmatic market, as do Google (DoubleClick), AOL, and Yahoo.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1558591\" data-linked=\"Rocket Fuel jumps on Goldman coverage launch\" data-tweet=\"$FUEL $FUEL $CRTO - Rocket Fuel jumps on Goldman coverage launch https://seekingalpha.com/news/1558591-rocket-fuel-jumps-on-goldman-coverage-launch?source=tweet\" data-url=\"https://seekingalpha.com/news/1558591-rocket-fuel-jumps-on-goldman-coverage-launch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558551\" data-ts=\"1392046184\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZPTAF\" target=\"_blank\">ZPTAF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558551-longview-oil-plus-10_2-percent-on-takeover-offer-but-few-details-released\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Longview Oil +10.2% on takeover offer but few details released</a></h4><ul>     <li>Longview Oil (LGVWF <font color=\"green\">+10.2%</font>) says it is reviewing an unsolicited, <a href=\"http://finance.yahoo.com/news/longview-announces-receipt-unsolicited-non-110000056.html\" target=\"_blank\">non-binding takeover offer</a> from an unidentified public company.</li>     <li>Longview provides few details except that the prospective bidder would pay for the deal with its own shares.</li>     <li>The company adopts a shareholder rights plan as a defensive move to provide its board with time to evaluate the offer and alternatives.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1558551\" data-linked=\"Longview Oil +10.2% on takeover offer but few details released\" data-tweet=\"$ZPTAF - Longview Oil +10.2% on takeover offer but few details released https://seekingalpha.com/news/1558551-longview-oil-plus-10_2-percent-on-takeover-offer-but-few-details-released?source=tweet\" data-url=\"https://seekingalpha.com/news/1558551-longview-oil-plus-10_2-percent-on-takeover-offer-but-few-details-released\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558541\" data-ts=\"1392045937\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYOU\" target=\"_blank\">CYOU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558541-sohu-changyou-slump-on-poor-guidance-changyou-cfo-departs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sohu, Changyou slump on poor guidance; Changyou CFO departs</a></h4><ul>\n<li>For the second straight quarter (<a href=\"https://seekingalpha.com/news/1360182-sohu-minus-10-percent-premarket-following-mixed-earnings-guidance\" target=\"_blank\">previous</a>), Sohu (<a href=\"https://seekingalpha.com/symbol/SOHU\" title=\"Sohu.com Inc.\">SOHU</a> <font color=\"red\">-3.6%</font>) and subsidiary Changyou (<a href=\"https://seekingalpha.com/symbol/CYOU\" title=\"Changyou.com Limited\">CYOU</a> <font color=\"red\">-12.5%</font>) are falling after posting mixed results and issuing light guidance.</li>\n<li>Sohu expects Q1 revenue of $355M-$367M and EPS of -$1.10 to -$1.20, below a consensus of $378.6M and breakeven. Changyou expects Q1 revenue of $174M-$180M and EPS of -$0.30 to -$0.42, below a consensus of $198.8M and $1.00.</li>\n<li>Along with its Q4 report, Changyou has announced CFO Alex Ho is <a href=\"http://finance.yahoo.com/news/changyou-announces-management-change-051500725.html\" target=\"_blank\">leaving</a> to \"start his own business.\" Finance director Erin Sheng will serve as interim CFO while the game developer searches for a permanent replacement.</li>\n<li>Changyou, responsible for over half of Sohu's Q4 revenue, attributes its guidance to a revenue drop for flagship title <em>TLBB</em>, seasonal ad weakness, and bigger marketing and personnel investments. Changyou also says it's implementing an employee profit-sharing plan tied to specific projects.</li>\n<li>Though its revenue rose 9% Y/Y, Changyou's monthly active accounts fell 19% Q/Q and 34% Y/Y to 25M, thanks to declining accounts for <em>TLBB</em> and <em>DDTank</em>. Platform channel accounts rose 51% Q/Q and 93% Y/Y to 149M.</li>\n<li>Changyou's opex soared 82% Q/Q and 156% Y/Y. Gross margin was 82%, -200 bps Q/Q and Y/Y.</li>\n<li>Sohu's Sogou search revenue rose 23% Q/Q and 72% Y/Y to $70M. Brand ad sales fell 1% Q/Q but rose 50% Y/Y to $123M.</li>\n<li>Sohu's opex rose 78% Y/Y, well above rev. growth of 29%. Gross margin fell 200 bps Q/Q and 500 bps Y/Y to 64%.</li>\n<li>Q4 results: <a href=\"https://seekingalpha.com/news/1557661-sohu-com-inc-beats-by-0_48-misses-on-revenue\" target=\"_blank\">Sohu</a>, <a href=\"https://seekingalpha.com/news/1557671-changyou-com-limited-beats-by-0_44-misses-on-revenue\" target=\"_blank\">Changyou</a>. PRs: Sohu, <a href=\"http://ir.changyou.com/02_10_2014.shtml\" target=\"_blank\">Changyou</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1558541\" data-linked=\"Sohu, Changyou slump on poor guidance; Changyou CFO departs\" data-tweet=\"$CYOU $SOHU $CYOU - Sohu, Changyou slump on poor guidance; Changyou CFO departs https://seekingalpha.com/news/1558541-sohu-changyou-slump-on-poor-guidance-changyou-cfo-departs?source=tweet\" data-url=\"https://seekingalpha.com/news/1558541-sohu-changyou-slump-on-poor-guidance-changyou-cfo-departs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558491\" data-ts=\"1392044300\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BWP\" target=\"_blank\">BWP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558491-boardwalk-pipeline-minus-37_7-percent-as-distributable-cash-flow-drops-dividend-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boardwalk Pipeline -37.7% as distributable cash flow drops, dividend cut</a></h4><ul>     <li>Boardwalk Pipeline Partners (NYSE:<a href=\"https://seekingalpha.com/symbol/BWP\" title=\"Boardwalk Pipeline Partners, LP\">BWP</a>) <font color=\"red\">-37.7%</font> after declaring a $0.10/unit quarterly dividend, an <a href=\"https://seekingalpha.com/news/1557721-boardwalk-pipeline-partners-lp-misses-on-revenue\" target=\"_blank\">81% decrease</a> from the prior dividend.</li>     <li>Distributable cash flow of $139M for Q4 and $558M for FY 2013 represented respective decreases of 3% and 12%  vs. 2012.</li>     <li>Results were hurt by lower transportation revenues due to contract expirations and contract renewals and lower parking, lending and storage revenues due to decreased parking opportunities from a reduction in the level of and volatility in natural gas price spreads between time periods.</li>\n<li>The distribution cut prompts Credit Suisse to <a href=\"http://www.streetinsider.com/Downgrades/Credit+Suisse+Downgrades+Boardwalk+Pipeline+Partners+%28BWP%29+to+Underperform/9143797.html\" target=\"_blank\">downgrade</a> BWP to Underperform from Neutral with a $20 price target, down from $32.</li>\n<li>Loews (NYSE:<a href=\"https://seekingalpha.com/symbol/L\" title=\"Loews Corporation\">L</a>), which owns 53% of BWP, is 3.8% lower; the company also released <a href=\"https://seekingalpha.com/news/1557711-loews-corporation-eps-of-minus-0_51\" target=\"_blank\">Q4 earnings</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1558491\" data-linked=\"Boardwalk Pipeline -37.7% as distributable cash flow drops, dividend cut\" data-tweet=\"$BWP $BWP $L - Boardwalk Pipeline -37.7% as distributable cash flow drops, dividend cut https://seekingalpha.com/news/1558491-boardwalk-pipeline-minus-37_7-percent-as-distributable-cash-flow-drops-dividend-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/1558491-boardwalk-pipeline-minus-37_7-percent-as-distributable-cash-flow-drops-dividend-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558481\" data-ts=\"1392044136\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEEL\" target=\"_blank\">SEEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558481-apricus-signs-vitaros-licensing-deal-shares-gain\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apricus signs Vitaros licensing deal, shares gain</a></h4><ul>   <li>Apricus' (APRI) shares <font color=\"green\">gain 8%</font> after the company signs an exclusive licensing agreement with Italy's Recordati (<a href=\"https://seekingalpha.com/symbol/RCDTF\" title=\"Recordati Industria Chimica e Farmaceutica S.p.A.\">OTCPK:RCDTF</a>) to market Apricus' Vitaros cream for erectile dysfunction in Spain, Russia, Turkey, Ireland and other European countries, and in some African markets.</li>    <li>Apricus will receive $3.8M up front, as much as $47M in sales milestone payments and royalties. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1558481\" data-linked=\"Apricus signs Vitaros licensing deal, shares gain\" data-tweet=\"$SEEL $SEEL $RCDTF - Apricus signs Vitaros licensing deal, shares gain https://seekingalpha.com/news/1558481-apricus-signs-vitaros-licensing-deal-shares-gain?source=tweet\" data-url=\"https://seekingalpha.com/news/1558481-apricus-signs-vitaros-licensing-deal-shares-gain\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558471\" data-ts=\"1392044113\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MWW\" target=\"_blank\">MWW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558471-monster-worldwide-settles-back-after-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Monster Worldwide settles back after downgrade</a></h4><ul> <li>Shares of Monster Worldwide (<a href='https://seekingalpha.com/symbol/MWW' title='Monster Worldwide, Inc.'>MWW</a>) get tripped up by a <a href=\"https://twitter.com/usratings/status/432863003940118528\" target=\"_blank\">downgrade</a> from FBR Capital on valuation concerns.</li> <li>The investment firm moves away from its bullish position, taking MWW to Market Perform from Outperform after seeing the stock go on a run.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1558471\" data-linked=\"Monster Worldwide settles back after downgrade\" data-tweet=\"$MWW - Monster Worldwide settles back after downgrade https://seekingalpha.com/news/1558471-monster-worldwide-settles-back-after-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/1558471-monster-worldwide-settles-back-after-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558461\" data-ts=\"1392043865\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FFIV\" target=\"_blank\">FFIV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558461-tech-ratings-changes-f5-fireeye-maxim-commvault\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tech ratings changes: F5, FireEye, Maxim, CommVault</a></h4><ul>\n<li>F5 (<a href=\"https://seekingalpha.com/symbol/FFIV\" title=\"F5 Networks, Inc.\">FFIV</a> <font color=\"green\">+1.1%</font>) has been started at Buy by Dougherty &amp; Co. The company <a href=\"https://seekingalpha.com/news/1520591-f5-networks-inc-beats-by-0_03-beats-on-revenue\" target=\"_blank\">beat FQ1 estimates</a> and issued <a href=\"https://seekingalpha.com/news/1520761-f5s-guidance-product-sales-growth-impresses-shares-plus-9_1-percent-ah\" target=\"_blank\">strong guidance</a> last month.</li>\n<li>FireEye (<a href=\"https://seekingalpha.com/symbol/FEYE\" title=\"FireEye, Inc.\">FEYE</a> <font color=\"green\">+3.7%</font>) has been started at Outperform by Wells Fargo. Q4 results arrive tomorrow.</li>\n<li>Maxim (<a href=\"https://seekingalpha.com/symbol/MXIM\" title=\"Maxim Integrated Products, Inc.\">MXIM</a> <font color=\"green\">+1.9%</font>) has been upgraded to Strong Buy by Raymond James.</li>\n<li>CommVault (<a href=\"https://seekingalpha.com/symbol/CVLT\" title=\"CommVault Systems, Inc.\">CVLT</a> <font color=\"green\">+0.6%</font>) has been upgraded to Outperform by JMP. Shares tanked two weeks ago due to the <a href=\"https://seekingalpha.com/news/1534201-commvault-falls-on-cautious-cc-remarks\" target=\"_blank\">cautious CC remarks</a> provided with an <a href=\"https://seekingalpha.com/news/1532751-commvault-systems-inc-beats-by-0_1-beats-on-revenue\" target=\"_blank\">FQ3 beat</a>.</li>\n<li>Ingram Micro (<a href=\"https://seekingalpha.com/symbol/IM\" title=\"Ingram Micro Inc.\">IM</a> <font color=\"green\">+1.8%</font>) has been upgraded to Buy by Brean.</li>\n<li>CalAmp (<a href=\"https://seekingalpha.com/symbol/CAMP\" title=\"CalAmp Corp.\">CAMP</a> <font color=\"green\">+2.2%</font>) has been started at Strong Buy by Midtown Partners.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1558461\" data-linked=\"Tech ratings changes: F5, FireEye, Maxim, CommVault\" data-tweet=\"$FFIV $FFIV $FEYE - Tech ratings changes: F5, FireEye, Maxim, CommVault https://seekingalpha.com/news/1558461-tech-ratings-changes-f5-fireeye-maxim-commvault?source=tweet\" data-url=\"https://seekingalpha.com/news/1558461-tech-ratings-changes-f5-fireeye-maxim-commvault\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558441\" data-ts=\"1392043530\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AUY\" target=\"_blank\">AUY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558441-yamana-gold-misses-2013-output-target-but-sees-stronger-2014\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yamana Gold misses 2013 output target but sees stronger 2014</a></h4><ul>     <li>Yamana Gold (<a href=\"https://seekingalpha.com/symbol/AUY\" title=\"Yamana Gold Inc.\">AUY</a> <font color=\"green\">+3.7%</font>) reports FY 2013 production that <a href=\"http://www.reuters.com/article/2014/02/10/yamana-production-idUSL2N0LF0ED20140210\" target=\"_blank\">fell short of its forecasts</a>, blaming the shortfall on problems at new operations that it says had been resolved by year's end.</li>     <li>AUY says it produced ~1.2M gold equiv. oz. in 2013 after earlier forecasting production of 1.32M-1.37M; for 2014, it expects to produce 1.4M god equiv. oz., at the low end of its previous forecast of 1.4M-1.5M.</li>     <li>AUY says all mines are now producing, which should raise the reliability of production and cost estimates going forward.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1558441\" data-linked=\"Yamana Gold misses 2013 output target but sees stronger 2014\" data-tweet=\"$AUY - Yamana Gold misses 2013 output target but sees stronger 2014 https://seekingalpha.com/news/1558441-yamana-gold-misses-2013-output-target-but-sees-stronger-2014?source=tweet\" data-url=\"https://seekingalpha.com/news/1558441-yamana-gold-misses-2013-output-target-but-sees-stronger-2014\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558421\" data-ts=\"1392042971\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SVRA\" target=\"_blank\">SVRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558421-mast-therapeutics-to-buy-blood-pressure-firm-aires\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mast Therapeutics to buy blood-pressure firm Aires</a></h4><ul>   <li>Mast Therapeutics (MSTX) has agreed to acquire Aires Pharmaceuticals, a privately held clinical-stage company developing therapies for pulmonary vascular disorders, in an all-stock deal.</li>    <li>Aires' lead product, AIR001, has orphan-drug status in the U.S. and Europe for pulmonary arterial hypertension.</li>    <li>Under the terms of the transaction, Aires will receive shares representing 6% of Mast's commons stock.</li>    <li>Adam Feuerstein <a href=\"https://twitter.com/adamfeuerstein/status/432882474482671617\" target=\"_blank\">tweets</a> that Mast is \"paying 6M shares of stock for Aires, or roughly $5M.\" Feuerstein also <a href=\"https://twitter.com/adamfeuerstein/status/432869638410878976\" target=\"_blank\">notes</a> that Novartis <a href=\"http://www.airespharma.com/news-articles/aires-pharmaceuticals-inc-completes-20m-equity-financing/\" target=\"_blank\">had an option</a> to acquire Aires but has apparently decided not to take it.</li>    <li>Notwithstanding, Mast's shares are <font color=\"green\">+5%</font>. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1558421\" data-linked=\"Mast Therapeutics to buy blood-pressure firm Aires\" data-tweet=\"$SVRA - Mast Therapeutics to buy blood-pressure firm Aires https://seekingalpha.com/news/1558421-mast-therapeutics-to-buy-blood-pressure-firm-aires?source=tweet\" data-url=\"https://seekingalpha.com/news/1558421-mast-therapeutics-to-buy-blood-pressure-firm-aires\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558371\" data-ts=\"1392041746\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTM\" target=\"_blank\">TTM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558371-tata-motors-surprises-in-fq3-led-by-jlr\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tata Motors surprises in FQ3 led by JLR</a></h4><ul> <li>Tata Motors (NYSE:<a href=\"https://seekingalpha.com/symbol/TTM\" title=\"Tata Motors Limited\">TTM</a>) rode a strong performance from Jaguar Land Rover to a big boost in quarterly profits.</li> <li>JLR vehicles sales were strong enough to help offset general weakness in India for Tata Motors.</li>  <li>TTM <font color=\"green\">+5.0%</font> premarket</li> </ul><div class=\"tiny-share-widget\" data-id=\"1558371\" data-linked=\"Tata Motors surprises in FQ3 led by JLR\" data-tweet=\"$TTM - Tata Motors surprises in FQ3 led by JLR https://seekingalpha.com/news/1558371-tata-motors-surprises-in-fq3-led-by-jlr?source=tweet\" data-url=\"https://seekingalpha.com/news/1558371-tata-motors-surprises-in-fq3-led-by-jlr\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558351\" data-ts=\"1392041633\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDCO\" target=\"_blank\">MDCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558351-fda-staff-divided-over-medicines-companys-cangrelor\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA staff divided over Medicines Company&#39;s Cangrelor</a></h4><ul>   <li>It seems that FDA staff are divided over Medicines Company's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MDCO\" title=\"The Medicines Company\">MDCO</a>) Cangrelor drug for preventing blood clots.</li>    <li>\n<a href=\"https://seekingalpha.com/news/1558181-medicines-company-receives-cangrelor-blow-from-fda\" target=\"_blank\">As noted</a>, one review has recommended that the drug should not be approved due to trial flaws.</li>    <li>However, ISI Group analyst Umer Raffat has pointed out that buried deep in an <a href=\"http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM385234.pdf\" target=\"_blank\">FDA briefing document</a>, another review has recommended approval of Cangrelor (see page 11 of the document).</li>    <li>Shares were down 13% earlier but have recovered somewhat and are <font color=\"red\">-5.8%. </font>\n</li>      <li>Given the sensitive nature of these reviews for the market, surely the FDA should have given equal billing to a summary of both opinions at the beginning of the briefing document.</li>     <li>The FDA's recommendations come ahead of a meeting of an advisory committee that is due to take place on Wednesday.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1558351\" data-linked=\"FDA staff divided over Medicines Company&#39;s Cangrelor\" data-tweet=\"$MDCO - FDA staff divided over Medicines Company&#39;s Cangrelor https://seekingalpha.com/news/1558351-fda-staff-divided-over-medicines-companys-cangrelor?source=tweet\" data-url=\"https://seekingalpha.com/news/1558351-fda-staff-divided-over-medicines-companys-cangrelor\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558341\" data-ts=\"1392041483\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558341-premarket-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers</a></h4><ul>\n<li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/AZC\" title=\"Augusta Resource Corporation\">AZC</a> <font color=\"green\">+28%</font>. <a href=\"https://seekingalpha.com/symbol/AMAP\" title=\"AutoNavi Holdings\">AMAP</a> <font color=\"green\">+25%</font>. <a href=\"https://seekingalpha.com/symbol/PLUG\" title=\"Plug Power, Inc.\">PLUG</a> <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/MPAA\" title=\"Motorcar Parts of America, Inc.\">MPAA</a> <font color=\"green\">+11%</font>. APRI <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/YELP\" title=\"Yelp\">YELP</a> <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/BLDP\" title=\"Ballard Power Systems, Inc.\">BLDP</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/KNDI\" title=\"Kandi Technologies Group, Inc.\">KNDI</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/CALL\" title=\"magicJack VocalTec Communications Ltd.\">CALL</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/CGEN\" title=\"Compugen Ltd.\">CGEN</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/DKS\" title=\"Dick's Sporting Goods, Inc.\">DKS</a> <font color=\"green\">+6%</font>. YOD <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/TTM\" title=\"Tata Motors Limited\">TTM</a> <font color=\"green\">+5%</font>. <a href=\"https://seekingalpha.com/symbol/SFUN\" title=\"Fang Holdings Ltd. ADS\">SFUN</a> <font color=\"green\">+5%</font>. <a href=\"https://seekingalpha.com/symbol/FUEL\" title=\"Rocket Fuel\">FUEL</a> <font color=\"green\">+6%</font>. GALE <font color=\"green\">+5%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/BWP\" title=\"Boardwalk Pipeline Partners, LP\">BWP</a> <font color=\"red\">-33%</font>. <a href=\"https://seekingalpha.com/symbol/CYOU\" title=\"Changyou.com Limited\">CYOU</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/SOHU\" title=\"Sohu.com Inc.\">SOHU</a> <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/SNSS\" title=\"Sunesis Pharmaceuticals, Inc.\">SNSS</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/MDCO\" title=\"The Medicines Company\">MDCO</a> <font color=\"red\">-6%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1558341\" data-linked=\"Premarket Gainers / Losers\" data-tweet=\"$AZC $AMAP $PLUG - Premarket Gainers / Losers https://seekingalpha.com/news/1558341-premarket-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1558341-premarket-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558291\" data-ts=\"1392040670\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JRCCQ\" target=\"_blank\">JRCCQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558291-james-river-coal-plus-25-percent-as-it-begins-evaluation-of-strategic-alternatives\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">James River Coal +25% as it begins evaluation of strategic alternatives</a></h4><ul>\n<li>James River Coal (JRCC) <font color=\"green\">+25.6%</font> premarket after Friday's announcement that it will <a href=\"https://seekingalpha.com/news/1557041-james-river-explores-strategic-options-amends-revolver-minus-16-percent-ah\" target=\"_blank\">explore a potential sale</a> and other strategic alternatives.</li>\n<li>Analysts say JRCC isn't poorly run, but is stuck with <a href=\"http://online.wsj.com/news/articles/SB10001424052702304680904579369331913033314\" target=\"_blank\">the wrong type of assets at the wrong time</a> - thermal coal prices have suffered as power companies turned to cleaner natural gas, and coal seams in Appalachia are deeper and thinner than elsewhere and thus more expensive to extract.</li>\n<li>JRCC should be able to find a buyer who wants to \"make a bet on having a thermal coal asset in an energy-constrained world.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1558291\" data-linked=\"James River Coal +25% as it begins evaluation of strategic alternatives\" data-tweet=\"$JRCCQ - James River Coal +25% as it begins evaluation of strategic alternatives https://seekingalpha.com/news/1558291-james-river-coal-plus-25-percent-as-it-begins-evaluation-of-strategic-alternatives?source=tweet\" data-url=\"https://seekingalpha.com/news/1558291-james-river-coal-plus-25-percent-as-it-begins-evaluation-of-strategic-alternatives\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558221\" data-ts=\"1392039858\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLUG\" target=\"_blank\">PLUG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558221-plug-power-plus-20-percent-on-multi-site-genkey-order\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Plug Power +20% on multi-site GenKey order</a></h4><ul>     <li>Plug Power (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PLUG\" title=\"Plug Power, Inc.\">PLUG</a>) <font color=\"green\">+20.6%</font> premarket on news it received a \"significant\" GenKey contract from a leading retailer to roll  out its turnkey hydrogen fuel cell system solutions at six North America  distribution centers over the next two years.</li>     <li>PLUG says the deal solidifies its position as the top global proton exchange membrane fuel cell system solution provider and shows that the technology has become mainstream.</li>\n<li>Peers also are higher premarket on the news: <a href=\"https://seekingalpha.com/symbol/BLDP\" title=\"Ballard Power Systems, Inc.\">BLDP</a> <font color=\"green\">+9.6%</font>, <a href=\"https://seekingalpha.com/symbol/FCEL\" title=\"FuelCell Energy, Inc.\">FCEL</a> <font color=\"green\">+2.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1558221\" data-linked=\"Plug Power +20% on multi-site GenKey order\" data-tweet=\"$PLUG $PLUG $BLDP - Plug Power +20% on multi-site GenKey order https://seekingalpha.com/news/1558221-plug-power-plus-20-percent-on-multi-site-genkey-order?source=tweet\" data-url=\"https://seekingalpha.com/news/1558221-plug-power-plus-20-percent-on-multi-site-genkey-order\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558191\" data-ts=\"1392039493\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AU\" target=\"_blank\">AU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558191-anglogold-ashanti-in-110m-deal-to-sell-namibia-mine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AngloGold Ashanti in $110M deal to sell Namibia mine</a></h4><ul>     <li>AngloGold Ashanti (NYSE:<a href=\"https://seekingalpha.com/symbol/AU\" title=\"AngloGold Ashanti Limited\">AU</a>) <font color=\"green\">+2.8%</font> premarket after agreeing to sell its Navachab mine in Namibia to QKR Corp.; the agreement provides for an upfront consideration based on an enterprise value of $110M.</li>\n<li>AU has been trying to sell Navachab for many months and wants to sell a number of projects as part of a restructuring.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1558191\" data-linked=\"AngloGold Ashanti in $110M deal to sell Namibia mine\" data-tweet=\"$AU - AngloGold Ashanti in $110M deal to sell Namibia mine https://seekingalpha.com/news/1558191-anglogold-ashanti-in-110m-deal-to-sell-namibia-mine?source=tweet\" data-url=\"https://seekingalpha.com/news/1558191-anglogold-ashanti-in-110m-deal-to-sell-namibia-mine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558181\" data-ts=\"1392039443\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDCO\" target=\"_blank\">MDCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558181-medicines-company-receives-cangrelor-blow-from-fda\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medicines Company receives Cangrelor blow from FDA</a></h4><ul>   <li>FDA staff have said that Medicines Company's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MDCO\" title=\"The Medicines Company\">MDCO</a>) Cangrelor drug for preventing blood clots should not be approved, with the treatment needing another trial in order to correct flaws in earlier studies.</li>    <li>The FDA's recommendation comes ahead of a meeting of an advisory committee that is due to take place on Wednesday.</li>    <li>Shares are <font color=\"red\">-13%</font>. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1558181\" data-linked=\"Medicines Company receives Cangrelor blow from FDA\" data-tweet=\"$MDCO - Medicines Company receives Cangrelor blow from FDA https://seekingalpha.com/news/1558181-medicines-company-receives-cangrelor-blow-from-fda?source=tweet\" data-url=\"https://seekingalpha.com/news/1558181-medicines-company-receives-cangrelor-blow-from-fda\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1558121\" data-ts=\"1392038163\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REGN\" target=\"_blank\">REGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1558121-regenerons-eylea-boosts-vision-in-patients-with-dme\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Regeneron&#39;s Eylea boosts vision in patients with DME</a></h4><ul>   <li>Regeneron's (<a href=\"https://seekingalpha.com/symbol/REGN\" title=\"Regeneron Pharmaceuticals, Inc.\">REGN</a> <font color=\"green\">+3.15%</font>) <a href=\"https://seekingalpha.com/news/search?query=Eylea\" target=\"_blank\">Eylea treatment</a> improved vision and maintained that improvement over two years in a Phase III trial of patients with diabetic macular edema (DME).</li>    <li>DME is a leading cause of blindness in younger and middle-aged adults; Eylea could potentially treat over 6M sufferers globally.</li>    <li>Regeneron and partner Bayer (<a href=\"https://seekingalpha.com/symbol/BAYRY\" title=\"Bayer A.G. ADR\">OTCPK:BAYRY</a>) are waiting for U.S. and EU approval of Eylea  to treat DME; the therapy has already been authorized for other indications, including  wet age-related macular edema. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1558121\" data-linked=\"Regeneron&#39;s Eylea boosts vision in patients with DME\" data-tweet=\"$REGN $REGN $BAYRY - Regeneron&#39;s Eylea boosts vision in patients with DME https://seekingalpha.com/news/1558121-regenerons-eylea-boosts-vision-in-patients-with-dme?source=tweet\" data-url=\"https://seekingalpha.com/news/1558121-regenerons-eylea-boosts-vision-in-patients-with-dme\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1557991\" data-ts=\"1392036987\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADDXF\" target=\"_blank\">ADDXF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1557991-addex-depression-drug-fails-in-trial-shares-dive\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Addex depression drug fails in trial, shares dive</a></h4><ul>   <li>Addex Therapeutics' (<a href=\"https://seekingalpha.com/symbol/ADDXF\" title=\"Addex Pharmaceuticals Ltd.\">OTC:ADDXF</a>) ADX71149 treatment for anxious depression was not more effective than a placebo in a Phase IIa trial.</li>    <li>The results don't \"support the further development of ADX71149 in anxious depression,\" Addex says, although the exploration of the drug for other purposes \"remains of potential interest.\"</li>    <li>Johnson &amp; Johnson (NYSE:<a href=\"https://seekingalpha.com/symbol/JNJ\" title=\"Johnson &amp; Johnson\">JNJ</a>) unit Janssen conducted the trial.</li>    <li>The failure is a major blow, as anxious depression is a leading cause of disability worldwide.</li>\n<li>Addex shares are <font color=\"red\">-27%</font> in Zurich. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1557991\" data-linked=\"Addex depression drug fails in trial, shares dive\" data-tweet=\"$ADDXF $ADDXF $JNJ - Addex depression drug fails in trial, shares dive https://seekingalpha.com/news/1557991-addex-depression-drug-fails-in-trial-shares-dive?source=tweet\" data-url=\"https://seekingalpha.com/news/1557991-addex-depression-drug-fails-in-trial-shares-dive\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1557961\" data-ts=\"1392036190\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KRG\" target=\"_blank\">KRG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1557961-kite-realty-to-buy-inland-diversified-for-1_2b-in-stock\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kite Realty to buy Inland Diversified for $1.2B in stock</a></h4><ul>     <li>Kite Realty (NYSE:<a href=\"https://seekingalpha.com/symbol/KRG\" title=\"Kite Realty Group Trust\">KRG</a>) <font color=\"green\">+10.5%</font> premarket on news the operator of community shopping centers agrees to acquire Inland Diversified Real Estate Trust for ~$1.2B in stock.</li>\n<li>KRG says the deal will allow it to enter markets including Westchester,  N.Y., Bayonne, N.J., Las Vegas, Virginia Beach and Salt Lake  City.</li>\n<li><a href=\"https://seekingalpha.com/news/1557821-kite-realty-group-trust-affo-in-line-beats-on-revenue\" target=\"_blank\">Q4 earnings</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"1557961\" data-linked=\"Kite Realty to buy Inland Diversified for $1.2B in stock\" data-tweet=\"$KRG - Kite Realty to buy Inland Diversified for $1.2B in stock https://seekingalpha.com/news/1557961-kite-realty-to-buy-inland-diversified-for-1_2b-in-stock?source=tweet\" data-url=\"https://seekingalpha.com/news/1557961-kite-realty-to-buy-inland-diversified-for-1_2b-in-stock\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1557901\" data-ts=\"1392035454\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BABA\" target=\"_blank\">BABA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1557901-alibaba-makes-a-run-for-full-control-of-autonavi\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alibaba makes a run for full control of AutoNavi</a></h4><ul> <li>Alibaba (ABABA) offers to <a href=\"http://dealbook.nytimes.com/2014/02/10/alibaba-seeks-control-of-autonavi-a-chinese-mapping-company/?_php=true&amp;_type=blogs&amp;_r=0\" target=\"_blank\">buy</a> the portion of AutoNavi (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AMAP\" title=\"AutoNavi Holdings\">AMAP</a>) it doesn't already own for $21 per ADS.</li> <li>The deal values AutoNavi at $1.58B.</li> <li>AMAP <font color=\"green\">+28.1%</font> premarket to $21.18.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1557901\" data-linked=\"Alibaba makes a run for full control of AutoNavi\" data-tweet=\"$BABA $BABA $AMAP - Alibaba makes a run for full control of AutoNavi https://seekingalpha.com/news/1557901-alibaba-makes-a-run-for-full-control-of-autonavi?source=tweet\" data-url=\"https://seekingalpha.com/news/1557901-alibaba-makes-a-run-for-full-control-of-autonavi\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1557871\" data-ts=\"1392034679\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAS\" target=\"_blank\">HAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1557871-hasbro-lower-after-sales-miss-in-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hasbro lower after sales miss in Q4</a></h4><ul> <li>Hasbro (NASDAQ:<a href=\"https://seekingalpha.com/symbol/HAS\" title=\"Hasbro, Inc.\">HAS</a>) saw strong growth in girls toys during Q4 led by Furby and My Little Pony, but the boys category saw a 16% dip.</li> <li>Segment revenue: U.S. and Canada -5% to $2,01B; International +5% to $1.873B; Entertainment and Licensing +5% to $191M (PR).</li>  <li>HAS <font color=\"red\">-3.0%</font> premarket</li> </ul><div class=\"tiny-share-widget\" data-id=\"1557871\" data-linked=\"Hasbro lower after sales miss in Q4\" data-tweet=\"$HAS - Hasbro lower after sales miss in Q4 https://seekingalpha.com/news/1557871-hasbro-lower-after-sales-miss-in-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/1557871-hasbro-lower-after-sales-miss-in-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1557751\" data-ts=\"1392032247\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFUN\" target=\"_blank\">SFUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1557751-soufun-holdings-limited-beats-by-0_32-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SouFun Holdings Limited beats by $0.32, beats on revenue</a></h4><ul>\n<li>SouFun Holdings Limited (NYSE:<a href=\"https://seekingalpha.com/symbol/SFUN\" title=\"Fang Holdings Ltd. ADS\">SFUN</a>): Q4 EPS of $1.42 <font color=\"green\">beats by $0.32</font>.</li>\n<li>Revenue of $217.2M (+47.2% Y/Y) <font color=\"green\">beats by $15.8M</font>.</li>\n<li>Shares <font color=\"green\">+1.2%</font> PM.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1557751\" data-linked=\"SouFun Holdings Limited beats by $0.32, beats on revenue\" data-tweet=\"$SFUN - SouFun Holdings Limited beats by $0.32, beats on revenue https://seekingalpha.com/news/1557751-soufun-holdings-limited-beats-by-0_32-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1557751-soufun-holdings-limited-beats-by-0_32-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1557631\" data-ts=\"1392025896\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1557631-global-stocks-mixed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Global stocks mixed</a></h4><ul>   <li>Many of the major stock indices in Europe and Asia have <a href=\"http://www.bloomberg.com/news/2014-02-10/japan-shares-lead-asian-stocks-higher-on-weaker-yen.html\" target=\"_blank\">continued to recover</a> from the sell-off during the first half of last week, encouraged by Wall Street's strong performance on Friday despite the tepid U.S. jobs report.</li>    <li>However, U.S. stock futures are flat-to-lower.</li>    <li>Markets are eyeing Janet Yellen's testimony to Congress tomorrow and on Thursday - her first appearance on Capitol Hill as Fed chief - for indications for the bank's reaction to the employment data.</li>    <li><a href=\"http://www.bloomberg.com/news/2014-02-10/china-s-stock-index-futures-rise-on-lunar-new-year-optimism.html\" target=\"_blank\">Chinese shares</a> led the gains in Asia with a <font color='green'>rise of 2%</font>, boosted by estimates of robust consumer spending during the Lunar New Year holiday season.</li>    <li>Japan <font color='green'>+1.8%</font>, Hong Kong <font color='red'>-0.3%</font>, India <font color='red'>-0.2%</font>.</li>    <li>EU Stoxx 50 <font color='green'>+0.2%</font>, London <font color='green'>+0.2%</font>, Paris <font color='green'>+0.4%</font>, Frankfurt <font color='green'>+0.3%</font>, Milan <font color='red'>-0.2%</font>, Madrid <font color='red'>-0.5%</font>.</li>     <li>U.S. stock futures: Dow <font color='red'>-0.2%</font>. S&amp;P <font color='red'>-0.2%</font>. Nasdaq flat.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1557631\" data-linked=\"Global stocks mixed\" data-tweet=\"Global stocks mixed https://seekingalpha.com/news/1557631-global-stocks-mixed?source=tweet\" data-url=\"https://seekingalpha.com/news/1557631-global-stocks-mixed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:51 AM </div></div></li>","count":57,"message":null,"success":true,"today":{"start":1576904400,"end":1576990799,"str":"Saturday, December 21, 2019"},"yesterday":{"start":1576818000,"end":1576904399}}